SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-08-239701
Filing Date
2008-11-20
Accepted
2008-11-20 07:21:51
Documents
8
Period of Report
2008-11-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 62966
2 SECOND AMENDMENT TO RIGHTS AGREEMENT dex41.htm EX-4.1 17264
3 SECURITIES PURCHASE AGREEMENT dex101.htm EX-10.1 311161
4 LINE OF CREDIT AGREEMENT dex102.htm EX-10.2 210537
5 PRESS RELEASE dex991.htm EX-99.1 20994
6 GRAPHIC g11795g26k90.jpg GRAPHIC 7759
7 GRAPHIC g11795g38p14.jpg GRAPHIC 22432
8 GRAPHIC g11795g41n37.jpg GRAPHIC 2627
  Complete submission text file 0001193125-08-239701.txt   670535
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31141 | Film No.: 081202443
SIC: 2834 Pharmaceutical Preparations